In Escherichia coli, a single operon encodes the metabolic and regulatory enzymes of the glyoxylate bypass. The metabolic enzymes, isocitrate lyase and malate synthase, are expressed from aceA and aceB, and the regulatory enzyme, isocitrate dehydrogenase kinase/phosphatase, is expressed from aceK. We cloned this operon and determined its functional map by deletion analysis. The order of the genes in this operon is aceB-aceA-aceK, with aceB proximal to the ptomoter, consistent with the results of previous experiments using genetic techniques. The promoter was identified by Si nuclease mapping, and its nucleotide sequence was determined. Isocitrate lyase and malate synthase were readily identified by autoradiography after the products of the operon clone were labeled by the maxicell procedure and then resolved by electrophoresis. In Cloning of the glyoxylate bypass operon. Two independent clones of the glyoxylate bypass operon were isolated. One isolate was subcloned from a plasmid carrying the appropriate region of the E. coli chromosome as a 20-kilobase (kb) insert. This plasmid, obtained from W. D. Nunn, had been constructed by partially digesting chromosomal DNA with Sau3A followed by ligation into the BamHI site of pBR322. (This procedure did not regenerate the BamHI sites.) To locate the glyoxylate bypass operon within this insert, we determined the restriction map of the plasmid and compared it with that of aceK (15). This comparison indicated that one of the fragments generated by the digestion of this plasmid with HindTll carried the operon and most of the vector sequences. The HindIII digest was ligated with T4 DNA ligase and used to transform strain MM294A to ampicillin 386 on July 7, 2017 by guest
In Escherichia coli, adaptation to growth on acetate requires the induction of the enzymes of the glyoxylate bypass: isocitrate lyase and malate synthase (12, 13) . This bypass is essential for growth on acetate since it prevents the net loss of the acetate carbons as carbon dioxide in the Krebs cycle (Fig. 1) . Once induced, the flow of isocitrate through the glyoxylate bypass is regulated, in part, by the phosphorylation of isocitrate dehydrogenase (IDH), the Krebs cycle enzyme which competes with isocitrate lyase (2, 8, 9, 11, 31) . During growth on acetate, ca. 70% of the IDH is maintained in the inactive phosphorylated form (4, 16, 18) , reducing the activity of this enzyme and thus forcing isocitrate through the bypass (19, 26) . The phosphorylation and dephosphorylation of IDH are catalyzed by a bifunctional enzyme, IDH kinase/phosphatase (17) , which is encoded by a single gene, aceK (15) .
In addition to being regulated by the phosphorylation of IDH, the glyoxylate bypass is regulated at the level of gene expression. Isocitrate lyase and malate synthase (expressed from aceA and aceB, respectively) are induced during growth on acetate and are repressed on most other carbon sources (12) . Brice and Kornberg (5) determined that aceA and aceB mapped close to each other at 90 min on the E. coli chromosome. Maloy and Nunn (22) subsequently found that these genes are in the same operon and that aceB is upstream from aceA. We have demonstrated that aceK is also in this operon, downstream of both aceB and aceA (18) . Thus, the organization of the glyoxylate bypass operon is aceB aceA aceK p where P indicates the promoter. The expression of the glyoxylate bypass operon is regulated, directly or indirectly, by the products of iclR and fadR (12, 22, 30) .
One of our long-term goals is to characterize the mechanisms which control the glyoxylate bypass operon and the factors which influence the differential expression of its products. Here, we report the cloning of this operon and the determination of its physical and functional maps. We also * Corresponding author.
used the maxicell procedure to confirm our previous observation of a striking downshift in expression between aceA and aceK (18) . MATERIALS Fig. 3, 4 , and 5.
To delete the promoter of the glyoxylate bypass operon, pCL8 was partially digested with BamHI and then digested to completion with EcoRI. The appropriate fragment was purified by electrophoresis and ligated between the EcoRI and BamHI sites of pBR322. Plasmid DNA was isolated from individual transformants, and its identity was confirmed by restriction mapping. (This procedure resulted in the deletion of the promoter of the tetracycline resistance gene.) The plasmid generated by this procedure, pCL800, is identical to its parent, pCL8, except for the removal of the insert sequences upstream of the first BamHI site (Fig. 2) .
Maxicell labeling. The maxicell technique was used to specifically label the protein products of the recombinant plasmids with [35S]methionine. The method used was similar to that described by Sancar et al. (28) , with the following significant modifications. The strain used for these experiments, MM294A, carried a recA mutation but not a uvrA mutation. Light-activated repair of chromosomal DNA was avoided by covering the cultures with aluminum foil after UV irradiation. Cells surviving the irradiation were killed by the addition of D-cycloserine to 200 jig/ml two h after irradiation. To induce expression from the promoter of the glyoxylate bypass operon, growth and labeling of MM294A, harboring the appropriate plasmid, were performed in minimal acetate medium. To specifically label IDH kinase/phosphatase, MM294A harboring pCL4 (which expresses aceK+ from the tac promoter) was grown on M63 medium supplemented with Casamino Acids and labeling was then performed in this medium without Casamino Acids.
After the labeling step, samples were subjected to sodium dodecyl sulfate-gel electrophoresis as described by Laemmli (14) . The gel was stained with methanol-acetic acid-water (5:1:5) containing 0.1% Coomassie brilliant blue R and destained with 10% acetic acid. The gel was then treated with En3Hance (New England Nuclear Corp.) as recommended by the manufacturer and dried. Autoradiography was performed at -70°C. Molecular weight standards were myosin (205,000), ,-galactosidase (116,000), phosphorylase b (97,400), bovine serum albumin (66,000), ovalbumin (45,000), and carbonic anhydrase (29,000).
Si nuclease mapping. Strain MM294A was grown to the mid-log phase on minimal acetate medium, and total RNA was isolated by the method of Summers (29) . Plasmid pCL1000 was end labeled at the BssHII sites by using T4 polynucleotide kinase and cleaved with ClaI, and the appropriate fragment was isolated by gel electrophoresis. S1 nuclease protection analysis was performed by the method of Berk and Sharp (3). The probe (ca. 100,000 cpm) was mixed with 50 jig of RNA and precipitated with ethanol. The sample was dissolved in 50 RI of 80% formamide-40 mM PIPES [piperazine-N-N'-bis(2-ethanesulfonic acid)] (pH 6.5)-400 mM NaCI-1 mM EDTA and then denatured for 10 min at 75°C. Hybridization was performed at 49°C for 4 h followed by the addition of 250 U of S1 nuclease in 500 ,ll of 30 mM sodium acetate (pH 4.6)-250 mM NaCl-1 mM ZnSO4-5% glycerol-20 pug of salmon sperm DNA per ml.
This reaction mixture was incubated at 37°C for 1 h. The reaction was stopped by the addition of 50 pI of 7.5 M ammonium acetate-100 mM EDTA, and the mixture was extracted with phenol-chloroform (1:1). The protected frag- (20) .
RESULTS
Cloning of the glyoxylate bypass operon. We isolated two independent clones of the glyoxylate bypass operon of E. coli (see Materials and Methods). These clones, designated pCL8 and pCL1000, carry the operon within inserts of 5 and 9.5 kb, respectively. Restriction mapping indicated that these inserts are identical (Fig. 2) Table 2 ). Both pCL8 and pCL1000 restored the ability of each of these strains to express the deficient enzyme, indicating that the full operon had been cloned. We also found that plasmid pCL8 yielded 10-to 20-fold overproductions of the operon products in wild-type strains (data not shown).
Plasmid pCL8 and the parental plasmid from which it was subcloned complemented the aceB mutation of strain 5236, restoring the ability of this strain to grow on a minimal acetate medium. Similarly, the parental plasmid complemented the aceA mutation in strain BN1 and the aceK mutation in strain DEK2011. In contrast, pCL8 did not complement the aceA or aceK mutation. consistent with similar results which we have obtained with plasmids which use the tac promoter (15) .
The products of pCL8 were examined by sodium dodecyl sulfate-gel electrophoresis after in situ labeling by the maxicell procedure (see Materials and Methods). In addition to 1-lactamase (molecular weight, 28,300), expressed from the bla gene of the vector two protein products were detectable (Fig. 3, lane 2) . Comparison of the electrophoretic mobilities of these proteins with that of IDH kinase/phosphatase, expressed from pCL4 (Fig. 3, lane 1) , indicated that neither of these bands corresponded to IDH kinase/phosphatase. One of these bands had an apparent molecular weight of 46,000, which is very similar to the apparent molecular 1 2 3 4 5 6 Fig. 4 and 5 (lanes 3 to 6) . K, Molecular weight in thousands. HindIIl site. Expression of the operon was induced by growing strain BN1 (aceA) harboring the appropriate plasmid to the stationary phase on L broth plus 2% sodium acetate. Cells were harvested by centrifugation, disrupted by sonication, and then assayed for isocitrate lyase activity, as described in the text. The numbers associated with two of the datum points indicate the clones which were subjected to maxicell analysis and correspond to the lane numbers in Fig. 3 . Restriction sites: *, BamHI; 0, AvaI; *, HindIll. The BssHII and PvuII sites are not shown.
weight, 48,000, reported for purified isocitrate lyase (27) . The remaining band, with an apparent molecular weight of 61,000, appears to be malate synthase. These assignments were confirmed by deletion mapping (see below). The failure to observe IDH kinase/phosphatase is consistent with our previous observation that the cellular level of isocitrate lyase appears to be 100-to 1,000-fold greater than that of IDH kinase/phosphatase (18) .
Mapping the 3' end of aceA. The location and transcriptional orientation of aceK had been determined by comparing its restriction map (15; Klumpp et al., submitted) with those of the operon clones (Fig. 2) . The 3' end of aceA was identified by examining the effects of serial deletions from the 3' end of the operon on the activity of isocitrate lyase (Fig. 4) . Isocitrate lyase activity was reduced by 90% by a deletion extending 200 base pairs (bp) upstream of aceK and was completely eliminated by deletions beyond this point. The 3' end of aceA thus appears to be ca. 200 bp upstream of aceK. Deletions beyond this point significantly reduced the size of the aceA product (Fig. 3, lane 3) , confirming its identity as isocitrate lyase.
We have confirmed the location of the 3' end of aceA while determining the sequence of aceK (Klumpp et al., submitted). The reading frame for aceA was identified by determining the junction sequence of an in-frame aceA-lacZ fusion gene. This open reading frame terminates 184 bp upstream of aceK. The deletion which yielded a 90% reduction in isocitrate lyase activity (Fig. 4 ) extended 14 bp upstream of this termination codon.
Mapping the 3' end of aceB. The 3' end of aceB, the gene encoding malate synthase, was also mapped by deletion analysis (Fig. 5) . A deletion extending 1,500 bp upstream from aceK reduced malate synthase activity by ca. 50% but had little effect on the size of the aceB product (Fig. 3, A series of nested deletions were introduced at the 3' end of the glyoxylate bypass operon within pCL8. For each deletion, the left endpoint is indicated and the right endpoint is at the Hindlll site. Strain 5236 (aceB glc), harboring the appropriate plasmid, was grown on MOPS medium containing 2% sodium acetate and 1% sodium succinate to the mid-log phase to induce the expression of the glyoxylate bypass operon. Cells were then harvested, disrupted by sonication, and assayed for malate synthase activity as described in the text. The numbers associated with some datum points indicate plasmids whose products were also characterized by maxicell labeling and correspond to the lane numbers in Fig. 3 . Restriction sites: *, BamHI; *, AvaI; *, HindIII. The BssHII and PvuII sites are not shown.
either downstream of aceB or was near its 3' end. (Translational readthrough into the vector sequences made very little contribution to the apparent molecular weight of the product of the truncated gene since translational termination codons occur in all three reading frames within 53 bp of the deletion endpoint.) Slightly larger deletions eliminated this activity and reduced the apparent molecular weight of the aceB product by ca. 2,000 (Fig. 3, lane 5) . Thus, the 3' end of aceB appears to be close to the endpoint of the smaller deletion. Substantially larger deletions resulted in a reduction in the apparent molecular weight of the aceB product (Fig. 3, lane  6 ), confirming the identity of this band as malate synthase.
Identification of the 5' end of the operon. The approximate location of the promoter of the glyoxylate bypass operon was determined by deletion mapping. Deletion of the internal BamHI fragment from pCL8, generating pCL9 (Fig. 2) , eliminated the expression of malate synthase but not that of isocitrate lyase or IDH kinase/phosphatase (Table 2 ). In contrast, deletion of the sequences upstream of the first BamHI site, yielding pCL800, eliminated the expression of all three products of this operon. These results indicate that the promoter is upstream of the first BamHI site.
The 5' end of the glyoxylate bypass operon mRNA, expressed from the chromosome, was mapped by S1 nuclease analysis by using the ClaI-BssHII fragment of pCL1000, which had been end labeled at the BssHII site. S1 digestion produced a single protected fragment with an electrophoretic mobility corresponding to a point 50 bp upstream of the first BamHI site in the insert (Fig. 6 ). Sequences immediately upstream of this site exhibit homology with the consensus E. coli promoter (Fig. 7) . These sequences agree with the consensus (10) (Fig. 8) as a further step in the characterization of the mechanism(s) of its control and the factors yielding differential expression of its products. The order of the genes determined by deletion mapping is consistent with the results of previous studies which used genetic techniques (18, 22) . The approximate sizes of aceA and aceB, 1.2 and 1.6 kb, respectively, are in good agreement with the apparent molecular weights of isocitrate lyase and malate synthase, 46,000 and 61,000, respectively. The results of S1 nuclease and deletion analysis indicate that the glyoxylate bypass operon is expressed from a single promoter during growth on acetate.
The glyoxylate bypass operon has recently been cloned from E. coli ML308 (7). The restriction map reported for the clone is in good agreement with those which we determined for the clones which we isolated. Although the functional map of the ML308 clone was not determined, it seems quite likely that the organization of the operon is similar to that reported here.
Although isocitrate lyase and malate synthase were readily identified after maxicell labeling of cells harboring pCL8, IDH kinase/phosphatase was not detected. This held true even when the gels were overloaded or when the films were subjected to prolonged exposures. This observation is consistent with the conclusion, based on enzymatic activities, that the cellular level of isocitrate lyase appears to be 100-to 1,000-fold greater than that of IDH kinase/phosphatase (18) . Thus, there appears to be a striking downshift in expression between aceA and aceK. This degree of polarity is probably advantageous to the cell since the products of this operon play very different roles: isocitrate lyase and malate synthase are metabolic enzymes, whereas IDH kinase/phosphatase is a regulatory protein.
The degree of polarity observed for the glyoxylate bypass operon is unusual but is not unique to this operon. For example, in E. coli, the cellular level of ribosomal protein S21 is 1,000-fold greater than that of DNA primase even though they are expressed from the same operon (6) . Similarly, a 10-to 20-fold difference in expression has been reported for the products of the rxcA operon of Rhodopseudomonas capsulata (1). For both operons, it has been proposed that polarity results, at least in part, from the rapid degradation of the downstream regions of the message (which correspond to the poorly expressed genes) by 3'-specific exonucleases. The upstream sequences appear to be stabilized by stem-loop structures at their 3' ends. Although the mechanism responsible for the downshift in expressipn between aceA and aceK remains to be determined, it is intriguing that potential stem-loop structures have been identified in the aceA-aceK intergenic region and within aceK (Klumpp et al., submitted). The mechanism responsible for this downshift is under continued study.
